Ecuador vs Israel: New cases tested for RR-/MDR-TB
Ecuador
100.0%
in 2024
Israel
100.0%
in 2024
Ecuador rank
1st
Israel rank
1st
New cases tested for RR-/MDR-TB over time
- Ecuador
- Israel
How they compare
Ecuador currently reports 100.0% against 100.0% in Israel, a difference of 0.0%.
Across all 16 years both countries report, Israel has been ahead every year.
Ecuador ranks 1st and Israel ranks 1st of 192 countries.
Israel has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Ecuador | Israel | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.4% | 100.0% | 96.6% | Israel |
| 2010s | 21.7% | 99.0% | 77.3% | Israel |
| 2020s | 95.8% | 100.0% | 4.2% | Israel |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Ecuador or Israel?
- Ecuador, at 100.0% against 100.0% in Israel as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Ecuador and Israel?
- 0.0%, with Ecuador ahead.
- How many years of comparable data are there for Ecuador and Israel?
- 16 years are reported by both, from 2005 to 2024.
- How do Ecuador and Israel rank globally for new cases tested for rr-/mdr-tb?
- Ecuador ranks 1st and Israel ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.